Dublin, Feb. 23, 2017 -- Research and Markets has announced the addition of the "Automated and Rapid Microbiological Tests - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Automated and Rapid Microbiological Tests in US$ Thousand by the following End-Use Segments:
Clinical Applications
- Automated Identification & Susceptibility Systems
- Automated Blood Culture Systems
- Automated Tuberculosis Systems
- Streptococcal Infection Rapid Tests
- GC/Chlamydia Rapid Tests
- Other Automated & Rapid Microbiological Tests
Non-Clinical Applications.
The report profiles 83 companies including many key and niche players such as
- Abbott Laboratories (US)
- Abbott Molecular, Inc. (US)
- Alere Inc. (US)
- Beckman Coulter, Inc. (US)
- Becton Dickinson and Company (US)
- bioMérieux SA (France)
- bioMerieux, Inc. (US)
- Bio-Rad Laboratories, Inc (US)
- Cellabs Pty Ltd (Australia)
- Cepheid Inc. (US)
- CorisBioconcept SPRL (Belgium)
- F. Hoffmann-La Roche AG (Switzerland)
- Hologic, Inc. (US)
- MedMira Inc. (Canada)
- Meridian Bioscience, Inc. (US)
- OraSure Technologies, Inc. (US)
- Orion Diagnostica Oy (Finland)
- QIAGEN N.V. (The Netherlands)
- Quidel Corporation (US)
- Sekisui Diagnostics, LLC (US)
- Siemens Healthcare GmbH (Germany)
- Thermo Fisher Scientific Inc. (US)
- Oxoid Limited (UK)
Key Topics Covered:
1. Industry Overview
2. Competition
3. Market Drivers And Trends
4. Key Issues Confronting The Rapid Microbiological Tests Market
5. Product/Technology Overview
6. Application Areas Of Automated And Rapid Microbiological Tests A Review
7. Product Innovations/Introductions
8. Recent Industry Activity
9. Focus On Select Global Players
10. Global Market Perspective
Total Companies Profiled: 83 (including Divisions/Subsidiaries - 90)
- The United States (55)
- Canada (1)
- Japan (4)
- Europe (27)
- France (3)
- Germany (9)
- The United Kingdom (3)
- Italy (2)
- Spain (1)
- Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (2)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/2m732j/automated_and
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers
CATL Stock Hits Record High After Q1 2025 Earnings Surge
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 



